Zhou et al., 2021 - Google Patents
Osteogenesis, Osteoclastogenesis and their Crosstalk in Lipopolysaccharide-induced Periodontitis in Mice.Zhou et al., 2021
View PDF- Document ID
- 14006035215223440871
- Author
- Zhou C
- Xu R
- Wu Z
- Zhang Z
- Yuan Q
- Zou S
- Xie J
- Zhang D
- Publication year
- Publication venue
- Chinese Journal of Dental Research
External Links
Snippet
Objective: To determine the crosstalk of osteogenesis and osteoclastogenesis of alveolar bone in lipopolysaccharide (LPS) induced periodontitis in mice. Methods: A representative periodontitis model was established by treating mice with LPS, and osteoblasts and …
- 239000002158 endotoxin 0 title abstract description 81
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhou et al. | Osteogenesis, Osteoclastogenesis and their Crosstalk in Lipopolysaccharide-induced Periodontitis in Mice. | |
| Yeh et al. | Hyperglycemia and xerostomia are key determinants of tooth decay in type 1 diabetic mice | |
| Zhang et al. | Tooth number abnormality: from bench to bedside | |
| Ikeda et al. | Resveratrol derivative‐rich melinjo seed extract induces healing in a murine model of established periodontitis | |
| Shi et al. | Crosstalk between reactive oxygen species and Dynamin-related protein 1 in periodontitis | |
| AU2023248161A1 (en) | Compositions and methods relating to myomixer-promoted muscle cell fusion | |
| Huang et al. | Bone resorption deficiency affects tooth root development in RANKL mutant mice due to attenuated IGF-1 signaling in radicular odontoblasts | |
| Otaify et al. | Gnathodiaphyseal dysplasia: severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5) | |
| Gong et al. | 1, 25‐dihydroxyvitamin D deficiency accelerates alveolar bone loss independent of aging and extracellular calcium and phosphorus | |
| Liu et al. | Osteoprotegerin-knockout mice developed early onset root resorption | |
| Zhao et al. | Cyclosporine A promotes bone remodeling in LPS‐related inflammation via inhibiting ROS/ERK signaling: studies in vivo and in vitro | |
| Bastos et al. | Hypertension may affect tooth‐supporting alveolar bone quality: a study in rats | |
| KR101322390B1 (en) | Screening method for the composition for prevention or treatment of osteoporosis and metabolic bone disease using TALLYHO/JngJ mouse | |
| Zhang et al. | Vitamin D receptor deficiency affects dentin maturation in mice | |
| US12090166B2 (en) | Pharmaceutical composition for preventing or treating dentin-dental pulp disease or periodontal disease, containing LPAR2 inhibitor | |
| Chen et al. | In vitro and in vivo study of the pathogenic role of PPARα in experimental periodontitis | |
| KR101534395B1 (en) | A composition for preventing or treating bone disorders, comprising trapidil | |
| Hayes et al. | Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin‐Deficient D2. B10‐Dmdmdx/J Mouse | |
| Zhang et al. | Effect of periodontal pathogens on total bone volume fraction: A phenotypic study | |
| Luo et al. | DNA damage‐inducible transcript 3 deficiency promotes bone resorption in murine periodontitis models | |
| Dorotheou et al. | Increased cell proliferation and gene expression of genes related to bone remodeling, cell adhesion and collagen metabolism in the periodontal ligament of unopposed molars in growing rats | |
| CN110200967A (en) | Application of 1 inhibitor of TGF-β in the drug of preparation treatment diabetes knitting obstacle | |
| WO2014084085A1 (en) | Prophylactic/therapeutic agent for hearing disorder or cerebellar ataxia | |
| Wang et al. | The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation | |
| JP5404279B2 (en) | Method for screening periodontal disease preventive agent and / or ameliorating agent and method for producing periodontal disease animal model used in the method |